Aaron Leong1, Bianca Porneala2, Josée Dupuis3, Jose C Florez4, James B Meigs5. 1. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA Harvard Medical School, Boston, MA. 2. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA. 3. Department of Biostatistics, Boston University School of Public Health, Boston, MA. 4. Harvard Medical School, Boston, MA Center for Human Genetic Research and Diabetes Unit, Massachusetts General Hospital, Boston, MA Program in Medical and Population Genetics, Broad Institute, Cambridge, MA. 5. Division of General Internal Medicine, Massachusetts General Hospital, Boston, MA Harvard Medical School, Boston, MA jmeigs@mgh.harvard.edu.
Abstract
OBJECTIVE: Type 2 diabetes (T2D) is associated with increased mortality in ethnically diverse populations, although the extent to which this association is genetically determined is unknown. We sought to determine whether T2D-related genetic variants predicted all-cause mortality, even after accounting for BMI, in the Third National Health and Nutrition Examination Survey. RESEARCH DESIGN AND METHODS: We modeled mortality risk using a genetic risk score (GRS) from a weighted sum of risk alleles at 38 T2D-related single nucleotide polymorphisms. In age-, sex-, and BMI-adjusted logistic regression models, accounting for the complex survey design, we tested the association with mortality in 6,501 participants. We repeated the analysis within ethnicities (2,528 non-Hispanic white [NHW], 1,979 non-Hispanic black [NHB], and 1,994 Mexican American [MA]) and within BMI categories (<25, 25-30, and ≥30 kg/m(2)). Significance was set at P < 0.05. RESULTS: Over 17 years, 1,556 participants died. GRS was associated with mortality risk (OR 1.04 [95% CI 1.00-1.07] per T2D-associated risk allele, P = 0.05). Within ethnicities, GRS was positively associated with mortality risk in NHW and NHB, but not in MA (0.95 [0.90-1.01], P = 0.07). The negative trend in MA was largely driven by those with BMI <25 kg/m(2) (0.91 [0.82-1.00]). In NHW, the positive association was strongest among those with BMI ≥30 kg/m(2) (1.07 [1.02-1.12]). CONCLUSIONS: In the U.S., a higher T2D genetic risk was associated with increased mortality risk, especially among obese NHW. The underlying genetic basis for mortality likely involves complex interactions with factors related to ethnicity, T2D, and body weight.
OBJECTIVE:Type 2 diabetes (T2D) is associated with increased mortality in ethnically diverse populations, although the extent to which this association is genetically determined is unknown. We sought to determine whether T2D-related genetic variants predicted all-cause mortality, even after accounting for BMI, in the Third National Health and Nutrition Examination Survey. RESEARCH DESIGN AND METHODS: We modeled mortality risk using a genetic risk score (GRS) from a weighted sum of risk alleles at 38 T2D-related single nucleotide polymorphisms. In age-, sex-, and BMI-adjusted logistic regression models, accounting for the complex survey design, we tested the association with mortality in 6,501 participants. We repeated the analysis within ethnicities (2,528 non-Hispanic white [NHW], 1,979 non-Hispanic black [NHB], and 1,994 Mexican American [MA]) and within BMI categories (<25, 25-30, and ≥30 kg/m(2)). Significance was set at P < 0.05. RESULTS: Over 17 years, 1,556 participants died. GRS was associated with mortality risk (OR 1.04 [95% CI 1.00-1.07] per T2D-associated risk allele, P = 0.05). Within ethnicities, GRS was positively associated with mortality risk in NHW and NHB, but not in MA (0.95 [0.90-1.01], P = 0.07). The negative trend in MA was largely driven by those with BMI <25 kg/m(2) (0.91 [0.82-1.00]). In NHW, the positive association was strongest among those with BMI ≥30 kg/m(2) (1.07 [1.02-1.12]). CONCLUSIONS: In the U.S., a higher T2D genetic risk was associated with increased mortality risk, especially among obese NHW. The underlying genetic basis for mortality likely involves complex interactions with factors related to ethnicity, T2D, and body weight.
Authors: Jonna L Grimsby; Bianca C Porneala; Jason L Vassy; Quanhe Yang; José C Florez; Josée Dupuis; Tiebin Liu; Ajay Yesupriya; Man-Huei Chang; Renee M Ned; Nicole F Dowling; Muin J Khoury; James B Meigs Journal: BMC Med Genet Date: 2012-04-27 Impact factor: 2.103
Authors: Michael V Holmes; Leslie A Lange; Tom Palmer; Matthew B Lanktree; Kari E North; Berta Almoguera; Sarah Buxbaum; Hareesh R Chandrupatla; Clara C Elbers; Yiran Guo; Ron C Hoogeveen; Jin Li; Yun R Li; Daniel I Swerdlow; Mary Cushman; Tom S Price; Sean P Curtis; Myriam Fornage; Hakon Hakonarson; Sanjay R Patel; Susan Redline; David S Siscovick; Michael Y Tsai; James G Wilson; Yvonne T van der Schouw; Garret A FitzGerald; Aroon D Hingorani; Juan P Casas; Paul I W de Bakker; Stephen S Rich; Eric E Schadt; Folkert W Asselbergs; Alex P Reiner; Brendan J Keating Journal: Am J Hum Genet Date: 2014-01-23 Impact factor: 11.025
Authors: Jason L Vassy; Marie-France Hivert; Bianca Porneala; Marco Dauriz; Jose C Florez; Josée Dupuis; David S Siscovick; Myriam Fornage; Laura J Rasmussen-Torvik; Claude Bouchard; James B Meigs Journal: Diabetes Date: 2014-02-11 Impact factor: 9.337
Authors: Alberto Montesanto; Anna Rita Bonfigli; Maria De Luca; Paolina Crocco; Paolo Garagnani; Elena Marasco; Chiara Pirazzini; Cristina Giuliani; Fabio Romagnoli; Claudio Franceschi; Giuseppe Passarino; Roberto Testa; Fabiola Olivieri; Giuseppina Rose Journal: Sci Rep Date: 2019-07-17 Impact factor: 4.379
Authors: Gordon P Watt; Susan P Fisher-Hoch; Mohammad H Rahbar; Joseph B McCormick; Miryoung Lee; Audrey C Choh; Sadagopan Thanikachalam; Mohan Thanikachalam Journal: BMJ Open Diabetes Res Care Date: 2018-03-20